Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Oxford Nanopore Technologies, Twist Bioscience, Mesa Biotech

Oxford Nanopore Technologies GridIon Mk1

Oxford Nanopore Technologies has launched GridIon Mk1, an upgrade to its GridIon X5 sequencing platform that will start shipping this week. The new version contains more powerful GPU technology, specifically a Nvidia Volta GV100 card, so basecalling now only requires 10 percent of the GPU resource. In addition, the firm said that it has simplified the power requirements, which increases the platform's stability.

Twist Bioscience Long Oligonucleotides

San Francisco-based Twist Bioscience has launched its long oligonucleotides product line. According to the firm, the synthetic nucleotides can be up to 300 bases and will increase the success and productivity of biological research. While adding bases normally introduces the risk of error, Twist said it has developed a proprietary way to make oligos with an error rate as low as 1:1500 nucleotides.

Mesa Biotech Accula RSV Test

San Diego, California-based molecular diagnostics developer Mesa Biotech has launched a respiratory syncytial virus test on its sample-to-answer point-of-care PCR Acula system. According to the firm, the RSV test is the second test on Acula, which also runs an influenza A/B test and is exclusively marketed in the US by Sekisui under the Silaris brand. The US Food and Drug Administration cleared the test in 2018, and the test has also been CLIA-waived for diagnostic use for both children and adults.

For more new products and services, please visit the New Products page on our website.